by: Edward B. Mulligan V, Attorney On February 12, 2013, the federal Judicial Panel on Multidistrict Litigation (JPML) transferred some 134 cases ... Read More
pharmaceutical
Debunking the Role of the FDA
Rarely does a month go by without a pharmaceutical or medical device company making headline news for illegal marketing or failing to disclose ... Read More
How a Plaintiff’s Attorney Thinks
I recently had a conversation with a lawyer for a large pharmaceutical manufacturer. We were discussing the merits of a particular mass tort case. ... Read More
Mass Torts v. Class Actions
People generally assume that because someone is a lawyer, they must know about every area of law. While lawyers might have a basic understanding of ... Read More
